Company intelligence
Fore Biotherapeutics
A precision oncology company rooted in science and innovation, focused on developing unique cancer therapies
Biotechnology
Philadelphia, US
55 employees
2 public signals
About Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies aimed at patients with unaddressed mutations across well-established oncology targtes. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.
Verified activity
Signals from Fore Biotherapeutics
2 published signals
Presence & Recognition
Fore Biotherapeutics is participating in two upcoming investor conferences in September, Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, and Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15.
Reported by Fore Biotherapeutics
Research & Knowledge
Fore Biotherapeutics announced a positive outcome from the planned interim efficacy analysis of the Fusions Basket in the FORTE study evaluating plixorafenib as a monotherapy in patients with BRAF-altered advanced solid tumors.
Reported by Fore Biotherapeutics